Human ARHGAP22/RhoGAP2/RhoGap22 ORF/cDNA clone-Lentivirus plasmid (NM_001256024.1)

Cat. No.: pGMLV000693
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human ARHGAP22/RhoGAP2/RhoGap22 Lentiviral expression plasmid for ARHGAP22 lentivirus packaging, ARHGAP22 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to ARHGAP22/RhoGAP2 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1029.3
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLV000693
Gene Name ARHGAP22
Accession Number NM_001256024.1
Gene ID 58504
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2145 bp
Gene Alias RhoGAP2,RhoGap22
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCTGAGCCCAAAGATCAGGCAGGCCAGGAGGGCCCGCTCCAAAAGCCTAGTGATGGGGGAGCAGAGCCGGAGCCCTGGGCGGATGCCGTGCCCTCACAGGCTGGGCCCCGTGCTGAAGGCGGGCTGGCTGAAGAAGCAGAGGAGCATCATGAAGAACTGGCAGCAGCGCTGGTTTGTGCTGCGTGGGGATCAGCTTTTCTACTACAAGGACAAAGATGAGATCAAGCCCCAGGGATTTATTTCTCTACAAGGGACACAGGTGACTGAACTTCCTCCTGGCCCCGAGGACCCAGGGAAGCACCTCTTTGAGATCAGCCCAGGTGGTGCCGGGGAGCGGGAGAAGGTGCCGGCCAACCCCGAGGCGCTCCTGCTCATGGCCAGCTCCCAGCGTGACATGGAGGACTGGGTGCAGGCCATCCGCCGAGTCATCTGGGCCCCGCTGGGCGGAGGTACTGCCCGTAGATCGCATGCCCACCCTCTAGAACCCTTGCCTCCAGGGATCTTTGGGCAGCGCCTAGAGGAAACAGTCCACCACGAGCGGAAGTATGGCCCCCGCCTGGCGCCCCTGCTGGTGGAGCAGTGTGTGGACTTCATCCGGGAGCGCGGGCTCACTGAGGAGGGGCTGTTCCGCATGCCAGGCCAGGCCAACCTGGTGAGGGACCTGCAGGATTCCTTCGACTGTGGGGAGAAGCCACTGTTTGACAGCACAACAGACGTGCACACGGTGGCCTCCCTGCTGAAGCTGTACCTGCGGGAGCTCCCCGAGCCCGTGGTCCCCTTCGCCAGGTACGAGGACTTCCTCAGCTGCGCCCAGCTGCTCACCAAGGACGAGGGGGAGGGCACTCTGGAGTTGGCTAAACAAGTGAGCAACCTTCCTCAGGCAAATTACAACCTGCTCAGATACATCTGCAAGTTTCTGGATGAAGTTCAGGCATACTCAAATGTCAACAAGATGAGTGTCCAGAATCTGGCAACCGTTTTTGGACCTAACATTCTGCGGCCACAGGTAGAGGACCCAGTAACCATCATGGAAGGCACTTCCCTCGTCCAGCACCTGATGACCGTCCTCATCCGCAAACACAGCCAGCTCTTCACGGCACCGGTCCCGGAAGGGCCCACCTCCCCGCGCGGGGGCCTGCAATGCGCAGTGGGGTGGGGCTCCGAGGAGGTCACCAGGGACAGCCAAGGAGAGCCCGGCGGCCCCGGCCTGCCCGCGCACAGGACCTCTTCCCTGGACGGGGCGGCCGTGGCGGTGCTCTCCAGAACAGCCCCCACGGGGCCGGGGAGCCGGTGCAGCCCTGGGAAGAAGGTGCAGACCCTGCCCAGTTGGAAGTCCTCCTTCCGGCAGCCGAGGTCCCTATCGGGAAGCCCGAAGGGGGGCGGCTCATCCCTGGAGGTGCCCATCATCTCCTCCGGCGGGAACTGGCTTATGAACGGGCTGTCCTCCCTGCGCGGACACCGCCGGGCCTCGTCGGGAGACCGGCTCAAGGACTCGGGCTCCGTGCAGAGACTCTCCACCTACGACAATGTGCCCGCGCCGGGCCTGGTCCCCGGCATACCCAGCGTGGCCAGTATGGCGTGGTCCGGGGCCTCGTCCAGCGAGTCGTCGGTGGGGGGCTCACTCAGCAGCTGCACGGCCTGCCGCGCCAGCGACTCGTCTGCCCGCAGTTCCCTGCACACCGACTGGGCCCTGGAGCCCTCCCCGCTCCCCAGCAGCAGCGAGGACCCCAAGTCCCTGGACCTGGACCACAGCATGGACGAGGCGGGCGCGGGTGCCAGCAACAGCGAGCCCAGCGAGCCGGACAGCCCCACCCGGGAACACGCGCGCCGCTCCGAGGCCTTACAGGGGCTGGTCACTGAGCTCAGGGCCGAGCTGTGCCGCCAGCGGACTGAGTACGAGAGGAGTGTGAAAAGAATCGAAGAAGGGAGTGCTGACCTGAGAAAACGAATGTCCCGGTTAGAAGAAGAACTGGACCAGGAAAAGAAAAAATACATCATGCTGGAAATAAAGCTGCGGAACTCTGAACGGGCGCGGGAGGATGCGGAGAGGAGGAACCAGCTGTTGCAGAGGGAAATGGAGGAGTTTTTTTCGACCCTAGGAAGCTTGACTGTTGGGGCAAAAGGTGCCAGGGCCCCAAAGTAA
ORF Protein Sequence MLSPKIRQARRARSKSLVMGEQSRSPGRMPCPHRLGPVLKAGWLKKQRSIMKNWQQRWFVLRGDQLFYYKDKDEIKPQGFISLQGTQVTELPPGPEDPGKHLFEISPGGAGEREKVPANPEALLLMASSQRDMEDWVQAIRRVIWAPLGGGTARRSHAHPLEPLPPGIFGQRLEETVHHERKYGPRLAPLLVEQCVDFIRERGLTEEGLFRMPGQANLVRDLQDSFDCGEKPLFDSTTDVHTVASLLKLYLRELPEPVVPFARYEDFLSCAQLLTKDEGEGTLELAKQVSNLPQANYNLLRYICKFLDEVQAYSNVNKMSVQNLATVFGPNILRPQVEDPVTIMEGTSLVQHLMTVLIRKHSQLFTAPVPEGPTSPRGGLQCAVGWGSEEVTRDSQGEPGGPGLPAHRTSSLDGAAVAVLSRTAPTGPGSRCSPGKKVQTLPSWKSSFRQPRSLSGSPKGGGSSLEVPIISSGGNWLMNGLSSLRGHRRASSGDRLKDSGSVQRLSTYDNVPAPGLVPGIPSVASMAWSGASSSESSVGGSLSSCTACRASDSSARSSLHTDWALEPSPLPSSSEDPKSLDLDHSMDEAGAGASNSEPSEPDSPTREHARRSEALQGLVTELRAELCRQRTEYERSVKRIEEGSADLRKRMSRLEEELDQEKKKYIMLEIKLRNSERAREDAERRNQLLQREMEEFFSTLGSLTVGAKGARAPK

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2347-Ab Anti-ARHGAP22 monoclonal antibody
    Target Antigen GM-Tg-g-IP2347-Ag ARHGAP22 protein
    ORF Viral Vector pGMLV000693 Human ARHGAP22 Lentivirus plasmid
    ORF Viral Vector vGMLV000693 Human ARHGAP22 Lentivirus particle


    Target information

    Target ID GM-IP2347
    Target Name ARHGAP22
    Gene ID 58504, 239027, 710956, 306279, 101095047, 100685787, 509022, 100063193
    Gene Symbol and Synonyms ARHGAP22,B230341L19Rik,p68RacGAP,RhoGAP2,RhoGap22
    Uniprot Accession Q7Z5H3
    Uniprot Entry Name RHG22_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000128805
    Target Classification Not Available

    This gene encodes a member of the GTPase activating protein family which activates a GTPase belonging to the RAS superfamily of small GTP-binding proteins. The encoded protein is insulin-responsive, is dependent on the kinase Akt and requires the Akt-dependent 14-3-3 binding protein which binds sequentially to two serine residues. The result of these interactions is regulation of cell motility. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.